SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 5348.
  • 2
    Conrad K, Melhorn J, Luthke K, Dorner T, Frank K-H. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 1996; 5: 629.
  • 3
    Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107 Suppl 5: 793802.
  • 4
    Linch KD, Miller WE, Althouse RB, Groce DW, Hale JM. Surveillance of respirable crystalline silica dust using OSHA compliance data (1979–1995). Am J Ind Med 1998; 34: 54758.
  • 5
    American Thoracic Society. Respiratory health hazards in agriculture. Am J Respir Crit Care Med 1998; 158: S176.
  • 6
    Schenker M. Exposures and health effects from inorganic agricultural dusts. Environ Health Perspect 2000; 108 Suppl 4: 6614.
  • 7
    Archer JD, Cooper GS, Reist PC, Storm JF, Nylander-French LA. Exposure to respirable crystalline silica in eastern North Carolina farm workers. Am Ind Hyg Assoc J. In press.
  • 8
    Bailey WC, Brown M, Buechner HA, Weill H, Ichinose H, Ziskind M. Silico-mycobacterial disease in sandblasters. Am Rev Respir Dis 1974; 110: 11525.
  • 9
    Koeger AC, Lang T, Alcaix D, Milleron B, Rozenberg S, Chaibi P, et al. Silica-associated connective tissue disease: a study of 24 cases. Medicine (Baltimore) 1995; 74: 22137.
  • 10
    Masson C, Audran M, Pascaretti C, Chevailler A, Subra JF, Tuchais E, et al. Silica-associated systemic erythematosus lupus or mineral dust lupus? Lupus 1997; 6: 13.
  • 11
    Brown LM, Gridley G, Olsen JH, Mellemkjaer L, Linet MS, Fraumeni JF Jr. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 1997; 39: 6338.
  • 12
    American Thoracic Society. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med 1997; 155: 7618.
  • 13
    Uber CL, McReynolds RA. Immunotoxicology of silica. Crit Rev Toxicol 1982; 10: 30319.
  • 14
    Pernis B, Paronetto F. Adjuvent effects of silica (tridymite) on antibody production. Proc Soc Exp Biol Med 1962; 110: 3902.
  • 15
    Levine S, Sowinski R. Enhancement of allergic encephalomyelitis by particulate adjuvants inoculated long before antigen. Am J Pathol 1980; 99: 291303.
  • 16
    Davis GS, Pfeiffer LM, Hemenway DR. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol 1998; 17: 99114.
  • 17
    Lim Y, Kim JH, Kim KA, Chang HS, Park YM, Ahn BY, et al. Silica-induced apoptosis in vitro and in vivo. Toxicol Lett 1999; 108: 3359.
  • 18
    Leigh J, Wang H, Bonin A, Peters M, Ruan X. Silica-induced apoptosis in alveolar and granulomatous cells in vivo. Environ Health Perspect 1997; 105 Suppl 5: 12415.
  • 19
    Botto M. Links between complement deficiency and apoptosis. Arthritis Res 2001; 3: 20710.
  • 20
    Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000; 76: 227324.
  • 21
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 22
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 23
    Cooper GS, Dooley MA, Treadwell EL, St.Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case–control study. Arthritis Rheum 2002; 46: 18309.
  • 24
    Cooper GS, Parks CG, Treadwell EL, St.Clair EW, Gilkeson GS, Cohen PL, et al. Differences by race, sex, and age in the clinical and immunologic features of recently-diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002; 11: 1617.
  • 25
    National Institute for Occupational Safety and Health. Review of the literature on crystalline silica. Cincinnati (OH): Department of Health and Human Services (NIOSH); 1983.
  • 26
    National Institute for Occupational Safety and Health. Potential for exposure during construction. Cincinnati (OH): Department of Health and Human Services (NIOSH); 1996.
  • 27
    Occupational Safety and Health Administration. Special Emphasis Program (SEP) for silicosis. Washington (DC): US Department of Labor Occupational Safety and Health Administration; 1997.
  • 28
    National Institute for Occupational Safety and Health. NIOSH pocket guide to chemical hazards. Washington (DC): US Department of Labor; 1990.
  • 29
    Occupational Safety and Health Administration. OSHA safety and health standards (29 CFR 1910): general industry. Washington (DC): US Department of Labor; 1983.
  • 30
    Stopford CM, Stopford W. Potential for respirable quartz exposure from North Carolina farm soils. Scand J Work Environ Health 1995; 21: 446.
  • 31
    United States Geological Survey. Soil systems map North Carolina. Reston (VA): US Department of Agriculture; 1983.
  • 32
    Siemiatycki J, Dewar R, Lakhani R, Nadon L, Richardson L, Gerin M. Cancer risks associated with 10 inorganic dusts: results from a case-control study in Montreal. Am J Ind Med 1989; 16: 54767.
  • 33
    Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
  • 34
    Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W. Scleroderma and occupational exposure. Scand J Work Environ Health 1995; 21: 28992.
  • 35
    Burns CJ, Laing TJ, Gillespie BW, Heeringa SG, Aleser KH, Mayes MO, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 1996; 23: 190411.
  • 36
    Lacey JV, Laing TJ, Gillespie BW, Schottenfeld D. Reply to Epidemiology of scleroderma among women: assessment of risk from exposure to silica and silicone [letter]. J Rheumatol 1997; 24: 1854.
  • 37
    Nuyts GD, van Vlem E, de Vos A, Daelemans RA, Rorive G, Elseviers MM, et al. Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol Dial Transplant 1995; 10: 11625.
  • 38
    Teschke K, Smith JC, Olshan AF. Evidence of recall bias in volunteered vs. prompted responses about occupational exposures. Am J Ind Med 2000; 38: 3858.
  • 39
    Engel LS, Keifer MC, Zahm SH. Comparison of a traditional questionnaire with an icon/calendar-based questionnaire to assess occupational history. Am J Ind Med 2001; 40: 50211.
  • 40
    Duell EJ, Millikan RC, Savitz DA, Schell MJ, Newman B, Tse CJ, et al. Reproducibility of reported farming activities and pesticide use among breast cancer cases and controls: a comparison of two modes of data collection. Ann Epidemiol 2001; 11: 17885.
  • 41
    Adimora AA, Schoenbach VJ, Martinson FE, Stancil TR, Donaldson KH. Driver's license and voter registration lists as population-based sampling frames for rural African Americans. Ann Epidemiol 2001; 11: 3858.
  • 42
    Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999; 9: 18895.
  • 43
    Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA. Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 1985; 42: 83843.
  • 44
    Martin JR, Griffin M, Moore E, Lochead JA, Edwards AC, Williams J, et al. Systemic sclerosis (scleroderma) in two iron ore mines. Occup Med (Lond) 1999; 49: 1619.
  • 45
    Huang SH, Hubbs AF, Stanley CF, Vallyathan V, Schnabel PC, Rojanasakul Y, et al. Immunoglobulin responses to experimental silicosis. Toxicol Sci 2001; 59: 10817.
  • 46
    Crapo JD, Harmsen AG, Sherman MP, Musson RA. Pulmonary immunobiology and inflammation in pulmonary diseases. Am J Respir Crit Care Med 2000; 162: 19836.
  • 47
    Bernstein M, Pairon JC, Morabia A, Gaudichet A, Janson X, Brochard P. Non-fibrous dust load and smoking in dental technicians: a study using bronchoalveolar lavage. Occup Environ Med 1994; 51: 237.
  • 48
    Sterling TD. Possible effects on occupational lung cancer from smoking related changes in the mucus content of the lung. J Chronic Dis 1983; 36: 66984.
  • 49
    Bergmann S, Siekmeier R, Mix C, Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respir Physiol 1998; 114: 26975.
  • 50
    Francus T, Klein RF, Staiano-Coico L, Becker CG, Siskind GW. Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol 1988; 140: 18239.
  • 51
    Koethe SM, Nelson KE, Becker CG. Activation of the classical pathway of complement by tobacco glycoprotein (TGP). J Immunol 1995; 155: 82635.
  • 52
    Slavin RE, Swedo JL, Brandes D, Gonzalez-Vitale JC, Osornio-Vargas A. Extrapulmonary silicosis: a clinical, morphologic, and ultrastructural study. Hum Pathol 1985; 16: 393412.
  • 53
    Gregorini G, Tira P, Frizza J, D'Haese PC, Elseviers MM, Nuyts G, et al. ANCA-associated diseases and silica exposure. Clin Rev Allergy Immunol 1997; 15: 2140.
  • 54
    Calvert GM, Steenland K, Palu S. End-stage renal disease among silica-exposed gold miners: a new method for assessing incidence among epidemiologic cohorts. JAMA 1997; 277: 121923.
  • 55
    Rapiti E, Sperati A, Miceli M, Forastieve F, Di Lallo D, Cavariani F, et al. End stage renal disease among ceramic workers exposed to silica. Occup Environ Med 1999; 56: 55961.
  • 56
    Steenland K, Sanderson W, Calvert GM. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 2001; 12: 40512.
  • 57
    Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001; 12: 13442.
  • 58
    Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon (France): IARC Scientific Publications; 1980. p. 74.